Floatz logo

Activated T Cells

Major Depressive Disorder

Baylor Research InstituteCell therapyN/AActive
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

129 Active assets in the Major Depressive Disorder cohort.

Asset / SponsorPhaseRating
EDIVOXETINE
Eli Lilly and Company
Phase 3BBB
(1S,2R)-MILNACIPRAN
Allergan
Phase 4BBB
Vortioxetine
Mayo Clinic
Phase 4BBB
Opc-34712
Nova Scotia Health Authority
Phase 4BBB
DESVENLAFAXINE
Pfizer
Phase 4BBB

View all 50 →

Same molecule, other indications

Activated T Cells is also rated in:

relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →
glioblastomaDormant
CC
Indicative ·
41 / 100
View asset →
Chronic Lymphocytic LeukemiaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →